Stock vs Stock Comparison

Illumina, Inc. vs Agilent Technologies, Inc.

ILMN wins the Tale of the Tape 5–4.

ILMN$170.93
A$137.40

🏆 Tale of the Tape

54
ILMNA
19.6%Profitability (Net Margin)18.8%
29.6xValuation (P/E)27.3x
18.5%Efficiency (ROIC)11.8%
7/9Health (Piotroski F)5/9
4.3Safety (Altman Z)4.6
-0.7%Growth (Rev YoY)6.7%
1.20Risk (Sharpe 1Y)0.32
1.44xBalance Sheet (D/E)0.89x
5.02%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.585
252-Day Correlation
0.429
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricILMNA
Market Cap$24.7B$38.2B
P/E Ratio29.6x27.3x
Forward P/E27.5x20.5x
P/B9.26x5.37x
Dividend Yield0.75%
Beta1.421.22

Quantitative Metrics

MetricILMNA
DCF Fair Value$107.79$50.34
DCF Upside-15.1%-57.1%
Piotroski F7/95/9
Altman Z4.304.57
Beneish M-2.50-2.46
FCF Yield5.02%3.41%
Net Debt/EBITDA0.0x0.7x
ROIC18.5%11.8%
WACC13.2%12.1%
ROIC – WACC5.3pp-0.3pp
Gross Margin66.1%52.4%
Net Margin19.6%18.8%
Rev Growth YoY-0.7%6.7%
Sharpe (1Y)1.200.32
Max Drawdown 3Y-68.9%
FCF Payout Ratio24%

ILMN Price

Loading chart...

A Price

Loading chart...

ETF Exposure

ILMN found in:

ARKG4.52%
ARKK1.36%
MDYG0.67%
SPMD0.64%
MDY0.64%
MDYV0.61%
VBR0.42%
VFQY0.35%
VHT0.31%
VB0.24%
VXF0.24%
VFMO0.10%
VONV0.06%
ESGV0.04%
SPTM0.03%
VTI0.03%
VONE0.03%
ONEO0.02%
QUS0.01%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ILMN vs A: Head-to-Head Analysis

Illumina, Inc. (ILMN) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ILMN leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ILMN generates a return on invested capital (ROIC) of 18.5% compared to A's 11.8%. This suggests ILMN is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ILMN and A is 0.585, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

ILMN appears in 19 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ILMN or A?

Our quantitative analysis compares ILMN and A across nine fundamental dimensions. ILMN wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ILMN and A correlated?

The 252-day correlation between ILMN and A is 0.585. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.